Windgap Medical Appoints Anthony (“Tony”) Watson as Vice President, Regulatory Affairs and Quality

Watertown, MA, April 10, 2023 — Windgap Medical is pleased to announce the appointment of Anthony Watson as the company’s Vice President, Regulatory Affairs and Quality, effective April 10. Watson will lead both functions at Windgap, collaborating closely with the CEO and the entire organization to progress the company’s multiple injection platforms.

“Tony brings significant experience with combination products to the Windgap team ,” said Aaron Mann, Windgap’s CEO.. “His hands-on experiences with drug delivery systems, medical devices, and digital therapeutics will serve both our customers and our injection platforms well.”

Watson joins Windgap from Pear Therapeutics where he was Vice President, Regulatory Affairs and Quality. Prior to Pear, Watson served in Regulatory leadership roles at Sanofi and at Biogen. Prior to Biogen, Watson held a series of leadership roles at the FDA, culminating as the Director, Office of Device Evaluation, CDRH. He holds MBA and MIS degrees from the University of Maryland, and a BS from the United States Naval Academy.

“I am excited to be join an innovative company like Windgap,” said Watson. “The technologies Windgap develops will be important advances for patients.”

ABOUT WINDGAP MEDICAL, INC

Windgap Medical, Inc. offers autoinjector platforms that simplify, automate, and accelerate the delivery of complex injectables, freeing patients, families, and potential cures from the limitations of current medical delivery technology. With an innovative design, development, and manufacturing process and an industry-leading team, Windgap’s “instant solutions” create a new frontier of pharmaceuticals for partners seeking to harness its wet-dry drug delivery technology and an increased speed to market. Its first product is for the administration of epinephrine for anaphylaxis, with additional products under development in a variety of markets.

Windgap Medical, Inc. is an emerging, privately held pharmaceutical company in the Greater Boston area.

FOR QUESTIONS, CONTACT:
Aaron Mann
Windgap Medical, Inc.
(339) 232-7759
press@windgapmedical.com

Previous
Previous

Windgap Medical Appoints Jason Durkin as Vice President, SupplyChain

Next
Next

Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO